Our study particularly highlights an involvement of RFX6 in epithelial‐mesenchymal transition (EMT), primarily by upregulating HOXA10, a potential oncogenic transcription factor with prognostic value in PCa. Here, HOXA10 is linked to posterior cortical atrophy.